期刊文献+

急性ST段抬高型心肌梗死直接介入治疗院内死亡原因分析 被引量:3

Causes of in-hospital death during direct percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的分析急性ST段抬高型心肌梗死(STEMI)患者直接经皮冠状动脉介入治疗(PCI)院内死亡原因。方法连续入选自首都医科大学附属北京潞河医院心内科2010年1月至2013年12月因STEMI行直接PCI院内死亡患者资料,回顾性分析其死亡原因。结果总计1314例STEMI患者进行直接PCI治疗,住院期间死亡44例,病死率3.3%;发病到就诊平均时间(5.3±4.6)h;43.8%的患者梗死相关血管为前降支,其中11例行经皮冠状动脉腔内成形术(PTCA),33例患者植入支架44枚,平均每例患者植入支架(1.1±0.8)枚。主要死亡原因为心源性休克56.8%,其次为心脏破裂占20.5%,15.9%死于血管并发症(包括无复流、支架内血栓、冠状动脉穿孔、夹层)。结论 STEMI患者直接PCI院内死亡原因依次为心源性休克、心脏破裂、血管并发症。 Objective To analyze the causes of in-hospital death during direct percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). Methods The data were collected from died STEMI patients during PCI from Jan. 2010 to Dec. 2013, and the death causes were retrospectively analyzed. Results There were totally 1314 STEMI patients undergone PCI, among them 44 died during hospitalization and mortality was 3.3%, and average onset-to-hospital time was (5.3 ±4.6) h. There were 43.8% cases with anterior descending infarction, among them 11 undergone percutaneous transluminal coronary angioplasty. There were 33 cases undergone implantation of 44 stents and average (1.1 ± 0.8) stents implanted in one case. The primary death causes were cardiogenic shock (56.8%), cardiac rupture (20.5%) and vascular complications (15.9%, including non-reflow, stent thrombosis, and coronary artery perforation and dissection). Conclusion The causes of in-hospital death during direct PCI are cardiogenic shock, cardiac rupture and vascular complications in STEMI patients.
出处 《中国循证心血管医学杂志》 2015年第1期125-127,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 急性ST段抬高型心肌梗死 经皮冠状动脉介入治疗 死亡 ST-segment elevation myocardial infarction Percutaneous coronary intervention Death
  • 相关文献

参考文献12

  • 1杨进刚,皮林,宋莉,孙艺红,胡大一.北京市急性ST段抬高型心肌梗死患者的院内预后和3年随访结果[J].中华心血管病杂志,2013,41(6):474-479. 被引量:37
  • 2Hudson MP,Armstrong PW,O' Nell ww,et al. Mortality implications ofprimary percutaneous coronary intervention treatment delays: insights from the assessment of pexelizumab inacutemyocardial infarction trial[J]. Cite CardiovascQual Outcomes,2011,4(2): 183-92.
  • 3无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量:1978
  • 4经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25. 被引量:546
  • 5宋雷,杨跃进,吕树铮,杨新春,李虹伟,郭金成,高炜,黄超联,方全,吴明营,郝恒剑.北京地区急性心肌梗死直接经皮冠状动脉介入治疗患者住院死亡原因分析[J].中华心血管病杂志,2012,40(7):554-559. 被引量:23
  • 6Addala S,Griner CL,Dixon SR,et al. Predicting mortalilyinpatients with ST elevation myocardial infarction treated withprimary pereutaneous coronary intervention ( PAMI risk score ) [J]. Anl J Cardiol,2004,93(5):629-32.
  • 7Garbo R,Steffenino G,Dellavalle A,et al. Myocardial infarction with acute thrombosis of multiple major coronary arteries: A clinical and angiographic observation in four patients[J]. Ital Heart J,2000,1(12):824-31.
  • 8Maagh P,Wiekenbrock I,Schrage MO,et al. Acute Simultaneous Proximal Occlusion of Two Major Coronary Arteries in Acute Myocardial Infarction: successful treatment with percutaneous coronary intervention[J]. J Interv Cardiol,2008,21(6):483- 92.
  • 9Goldberg RJ,Spencer FA,Gore JM,et al. Thirty-year trends (1975 to 2005)in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction : a population-based perspective[J]. Circulation,2009,119 (9):1211- 9.
  • 10Sugiura T,Nagahama Y,Nakamura S,et al. Left ventricular free wall rupture after reperfusion therapy for acute myocardial infarction[J]. Am J Cardiol,2003,92(3):282-4.

二级参考文献35

共引文献2555

同被引文献33

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部